Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
Genome Research|November 12, 2013
Discovery of recurrent structural variants in nasopharyngeal carcinomaAnton Valouev, Ziming Weng, Robert T Sweeney, et al.
Blood|July 31, 2013
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentJason Gotlib, Julia E Maxson, Tracy I George, et al.
Lancet (London, England)|August 29, 2021
Current and future status of JAK inhibitorsDonal P McLornan, Janet E Pope, Jason Gotlib, et al.
British Journal of Haematology|November 17, 2007
Gene expression and pathway analysis of immune thrombocytopenic purpuraRuchira Sood, Wendy Wong, Jason Gotlib, et al.
Development (Cambridge, England)|February 18, 2016
Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulatorsLori L O'Brien, Qiuyu Guo, YoungJin Lee, et al.
Hematology Reports|July 12, 2014
Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: a pilot studySteven M Chan, John Chadwick, Daniel L Young, et al.
Peerj|July 18, 2013
Feasibility of using microbeads with holographic barcodes to track DNA specimens in the clinical molecular laboratoryJason D Merker, Naomi O'Grady, Linda Gojenola, et al.
Genes|September 27, 2014
A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical CareScott D Boyd, Stephen J Galli, Iris Schrijver, et al.
Blood Reviews|April 27, 2020
Non-hematologic diagnosis of systemic mastocytosis: Collaboration of radiology and pathologyKerem Ozturk, Zuzan Cayci, Jason Gotlib, et al.
Blood Advances|September 10, 2021
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistanceJustin Anthony Chen, Yanli Hou, Krishna M Roskin, et al.
Pageof 28